Agoracom Blog Home

Archive for the ‘Featured’ Category

« Older Entries
Newer Entries »

St-Georges $SX SX.ca $SXOOF Retains Gravitas Securities Inc. as Strategic Financial Advisors #ZeU

Posted by AGORACOM-JC at 9:02 AM on Tuesday, March 20th, 2018

Sx large

  • Retained services of Gravitas Securities Inc. to act as financial advisors to St-Georges and its related entities
  • Gravitas will be tasked with assisting ZeU Crypto Networks Inc.
  • Currently in the process of acquiring all the intellectual properties of Tiande, a developer of permission-based blockchain protocol with BigData connectivity

Montreal / March 20, 2018 – St-Georges Eco-Mining Corp. (CSE: SX) (OTC: SXOOF) (FSE: 85G1) is pleased to announce that it has retained the services of Gravitas Securities Inc. to act as financial advisors to St-Georges and its related entities.

Gravitas will be tasked with assisting ZeU Crypto Networks Inc., St-Georges wholly-owned subsidiary, which is currently in the process of acquiring all the intellectual properties of Tiande, a developer of permission-based blockchain protocol with BigData connectivity. Gravitas will provide a number of services to ZeU including providing capital markets intelligence & guidance, financial & operational analysis of the company, and recommendations on capital requirements and strategic business decisions.

“With its contingent of Sino-Canadian personnel able to review our technology and business legal documentation in mandarin and the positive approach of the firm toward disruptive blockchain technologies, Gravitas is an excellent match for us. Their involvement should help us accelerate our financing effort with other securities firms and institutional investors. We also welcome their expertise to assist us for any corporate actions that might be undertaken in the coming months by the company” commented ZeU President Frank Dumas.

About Gravitas

Gravitas Securities is a leading wealth management and capital markets firm comprised of tactical individuals known for their sophisticated sector expertise, commitment to excellence, and a global platform committed to integration and innovation. Gravitas provides a wide range of investment services for retail and corporate clients globally with offices in Toronto and Vancouver, and is represented in the United States through its FINRA representative, Gravitas Capital International, in New York.

Gravitas Securities Inc. is a member of IIROC and CIPF.

ZeU Crypto Networks welcomes Lord Razzall as a director of the corporation

ZeU is pleased to welcome Lord Edward Timothy Razzall on its board of directors. Lord Razzall is a member of the British Parliament’ House of Lords and a Commander of the British Empire (CBE). Baron Razzall has been co-chair of the Liberal Democrat Parliamentary Committee on Business, Innovation and Science. He has over 35 years’ corporate finance experience and has developed a reputation for his expertise in multinational and cross border transactions. He was until recently the Liberal Democrat spokesman on Trade and industry and he’s now the Lords spokesman for manufacturing. He is currently Co-Chair of the Liberal Democrat Parliamentary Party Committee on Business, Innovation and Skills. Lord Razzall studied at Oxford University and qualified as a solicitor in 1969. ZeU expect to leverage Tim’s experience and interest in regulations, governance, monetary policies, intellectual property and corporate finance to its advantage.

ON BEHALF OF THE BOARD OF DIRECTORS

“Frank Dumas”

FRANK DUMAS, PRESIDENT & CEO

About St-Georges

St-Georges is developing new technologies to solve the some of the most common environmental problems in the mining industry.

The Company controls directly or indirectly, through rights of first refusal, all of the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & for industrial minerals on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi region. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1.

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

Tags: , , , ,
Posted in Bitcoin, Blockchain stocks, Blockstation, Canadian Blockchain Stocks, Featured, Smallcap Blockchain stocks, St Georges Eco-Mining Technologies | Comments Off on St-Georges $SX SX.ca $SXOOF Retains Gravitas Securities Inc. as Strategic Financial Advisors #ZeU

Esports Entertainment Group $GMBL Announces The Launch Of VIE.GG, The World’s Safest, Most Secure and Transparent #Esports #Wagering Platform $ATVI $TTWO $GAME $EPY.ca

Posted by AGORACOM-JC at 8:12 AM on Tuesday, March 20th, 2018

Esports large

  • Announced the launch of VIE  (https://vie.gg)
  • World’s safest, most secure and transparent esports wagering platform
  • bet exchange model provides for player versus player betting (PVP) with the house taking a small percentage of each wager
  • PVP model means a VIE player always wins and the Company removes all risk, creating a win-win for players and the Company

ST. MARY’S, ANTIGUA, March 20, 2018 — Esports Entertainment Group, Inc. (OTCQB:GMBL) (or the “Company”), a licensed online gambling company with a specific focus on esports wagering and 18+ gaming, is pleased to announce the launch of VIE  (https://vie.gg)  the world’s safest, most secure and transparent esports wagering platform.

VIE offers bet exchange style wagering on esports events in a licensed, regulated and secured platform to the global esports audience, excluding jurisdictions such as the USA that prohibit online gambling. The bet exchange model provides for player versus player betting (PVP) with the house taking a small percentage of each wager, as opposed to a sports book model that pits the player versus the house. Our PVP model means a VIE player always wins and the Company removes all risk, creating a win-win for our players and the Company.

The launch of VIE follows months of extensive, final financial compliance with applicable regulators, financial institutions and payment processors, as well as, beta testing that provided the Company with valuable feedback from esports enthusiasts around the world. VIE features wagering on the following esports games:

    • Counter-Strike: Global Offensive (CSGO)
    • Dota 2
    • Call of Duty
    • Hearthstone
    • StarCraft II

LAUNCH ROLL-OUT INCLUDES OVER 60 AFFILIATE STREAMERS AND WORLD LEADING SUPER AFFILIATE

A core element of the Company’s customer acquisition strategy is an affiliate program powered by Income Access, which won eGaming Review’s B2B Award for ‘Affiliate Software’ four years in a row. Income Access has been fully integrated into VIE to manage our affiliate program, which has received attention far beyond Company expectations to this point.

On September 6, 2017, the Company announced the signing of over 60 affiliate esports streamers at gamescom 2017, representing an audience of esports viewers which collectively generated over 250 million online video views in the preceding 30 days.

Some affiliates have already commenced the onboarding process, with the majority expected to be completed over the next 45 days. At that time, VIE will launch a contest for its affiliates that will feature significant prizes and rewards throughout 2018 to further incentivize registrations.  Moreover, with VIE now officially launched, the Company expects strong continual registrations of new affiliates throughout 2018 and beyond.

Grant Johnson, CEO of Esports Entertainment Group stated “Today marks a major milestone for Esports Entertainment Group, our investors and the entire esports industry.  With esports experiencing rapid global growth and set to hit mainstream sports in 2018 with the launch of initiatives such as NBA 2K later this year, esports fans have told us loud and clear that they want a licensed, secure and transparent wagering platform to augment their experience.  We are thrilled to launch and deliver VIE to them at this great time for esports.”
During the rollout, the Company expects to announce significant new features, including the addition of multiple languages such as Spanish and Russian next month and further additional languages until all the major languages of global esports enthusiasts are serviced.

This press release is available on our Online Investor Relations Community for shareholders and potential shareholders to ask questions, receive answers and collaborate with management in a fully moderated forum at https://agoracom.com/ir/EsportsEntertainmentGroup

About Esports Entertainment Group

Esports Entertainment Group Inc. is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Initially, Esports Entertainment intends to offer bet exchange style wagering on esports events in a licensed, regulated and secured platform to the global esports audience, excluding the US and EU. In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multi-player mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds licenses to conduct online gambling and 18+ gaming on a global basis, excluding the US and EU, in Curacao, Kingdom of the Netherlands and the Kahnawake Gaming Commission in Canada. The Company maintains offices in Antigua and  Poland. Esports Entertainment common stock is listed on the OTCQB under the symbol GMBL.  For more information visit www.esportsentertainmentgroup.com
.
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Corporate Finance Inquiries
Stephen Cotugno
Vice President, Corporate Development
[email protected]
201-220-5745

Investor Relations Inquiries
AGORACOM 
[email protected]
http://agoracom.com/ir/eSportsEntertainmentGroup

 

Tags: , , , , ,
Posted in All Recent Posts, Esports Entertainment Group, Esports Entertainment Group Inc., Featured | Comments Off on Esports Entertainment Group $GMBL Announces The Launch Of VIE.GG, The World’s Safest, Most Secure and Transparent #Esports #Wagering Platform $ATVI $TTWO $GAME $EPY.ca

$GR.ca Great Atlantic Completed Final Payment on Its 100% owned Keymet Precious – Base Metal Property, Bathurst, New Brunswick

Posted by AGORACOM at 8:00 AM on Tuesday, March 20th, 2018

  • Final option payment for its Keymet Precious – Base Metal Property, located near Bathurst, northeast New Brunswick
  • Seven vein occurrences with lead, zinc and +/- copper, silver and gold are reported in this region of the property
  • The Keymet Property is approximately 4 km north of the historic Nigadoo River Mine of which copper, lead, zinc and silver production from polymetallic veins occurred during the 1960s – 1970s.

Vancouver, British Columbia (FSCwire) – GREAT ATLANTIC RESOURCES CORP. (TSXV.GR) (the “Company” or “Great Atlantic”) is pleased to announce it has made the final option payment for its Keymet Precious – Base Metal Property, located near Bathurst, northeast New Brunswick. The property is reported to host numerous base metal – precious metal bearing veins including the historic Keymet Mine. The Company recently intersected mineralized veins northwest of the historic Keymet Mine including an intersection of 18.80% Zn, 3.55% Cu, 1.16 % Pb and 576 grams / tonne (g/t) Ag over 1.27 meters core length in a newly discovered vein and 3.54% Zn, 0.92% Cu and 115 g/t Ag over 12.05 meter core length plus 0.64 g/t Au over 19.96 meter core length in a newly discovered gold bearing zone (News Releases of December 20, 2017 and March 2, 2018). The Keymet Property is approximately 4 km north of the historic Nigadoo River Mine of which copper, lead, zinc and silver production from polymetallic veins occurred during the 1960s – 1970s.

To view the graphic in its original size, please click here

 

The Company’s focus since acquiring the Keymet Property has been the northwest region of the property. At least seven vein occurrences with lead, zinc and +/- copper, silver and gold are reported in this region of the property in addition to the polymetallic veins reported at the historic Keymet Mine (source: New Brunswick Dept. of Energy and Resource Development Mineral Occurrence Database). The Keymet Mine operated during the mid-1950s, producing copper, lead, zinc and silver.  Production at this mine was terminated due to a fire at the site.

Great Atlantic has explored two of these vein occurrences, the Elmtree 12 and Elmtree Silver Mine veins and adjacent areas, northwest of the historic Keymet Mine. A 20 meter deep shaft is reported at the Elmtree Silver Mine vein. A Qualified Person has located this shaft for Great Atlantic. Great Atlantic has intersected copper, lead, zinc and silver bearing veins at both the Elmtree 12 and Elmtree Silver Mine vein occurrences during 2015 and 2017 diamond drilling programs (9 total holes) with more significant results at the Elmtree 12 vein occurrence. Trenching at the Elmtree 12 vein occurrence also exposed such polymetallic veins. Gold mineralization was also locally intersected in host meta-sedimentary rocks in the general area of the Elmtree 12 vein occurrence. Highlights of this work included (as reported in News Releases of October 29, 2015, February 23, 2016, December 20, 2017 and March 2, 2018):

  • Ky-15-3 (Elmtree 12): 16.68% Zn, 1.11% Cu & 152 g/t Ag over 1.80 meter core length.
  • Ky-15-4 (Elmtree 12):  8.68% Zn, 0.29% Cu & 44.8 g/t Ag over 4.28 meter core length.
  • Ky-17-5 (Elmtree 12): 13.65% Zn, 1.20% Cu, 0.45% Pb & 166 g/t Ag over 0.80 meter core length.
  • Ky-17-6 (Elmtree 12): 3.54% Zn, 0.92% Cu, 0.28% Pb & 115.6 g/t Ag over 12.05 meter core length & 0.64 g/t Au over 19.96 meter core length (newly discovered gold bearing zone).
  • Ky-17-8: 18.80% Zn, 3.55% Cu, 1.16% Pb & 576 g/t Au over 1.27 meter core length (newly discovered polymetallic vein southwest of Elmtree 12 vein system).
  • 1.11 g/t Au over 4.9 meters in trench channel samples (vertically above drill hole Ky-17-8).

 

Polymetallic vein in Ky-15-4 (8.68% Zn, 0.29% Cu & 44.8 g/t Ag over 4.28 meter core length)

To view the graphic in its original size, please click here

 

Polymetallic Vein in Ky-17-6 (3.54% Zn, 0.92% Cu, 0.28% Pb & 115.6 g/t Ag over 12.05 meter core length)

To view the graphic in its original size, please click here

 

Polymetallic Vein material in Ky-17-8 (18.80% Zn, 3.55% Cu, 1.16% Pb & 576 g/t Ag over 1.27 meter core length (new discovery in 2017)

To view the graphic in its original size, please click here

 

To view the graphic in its original size, please click here

 

 

Copper, Zinc & Silver bearing vein in 2015 Trench (Elmtree 12 Vein System)

To view the graphic in its original size, please click here

 

A Qualified Person has verified this 2015 and 2017 exploration data for Great Atlantic. The Qualified Person managed the 2015 and 2017 exploration programs for Great Atlantic at the Keymet Property. True thickness of these intersections is unknown at this time.

Diamond drilling to date by the Company has been shallow with all but one hole less than 100 meter vertical depth and one hole to approximately 170 meter vertical depth. Planned 2018 diamond drilling will test both the Elmtree 12 vein system and newly discovered vein in Ky-17-8 along strike and at depth. -Drilling is also planned to test the continuation of the newly discovered gold zone intersected in hole Ky-17-6.

Arsenopyrite bearing metasediment boulder samples collected by Company prospectors in 2011 approximately 1.5 km northwest of the historic Keymet Mine were reported to return up to 51 g/t Au (News Release of March 2, 2012). A Qualified Person has not verified this sample data. This is the general area of the Elmtree 12 vein occurrence.

Additional gold occurrences are reported within the Keymet Property as per the New Brunswick Dept. of Energy and Resource Development Mineral Occurrence Database.  Two of these gold occurrences are reported in the east region of the Keymet Property.  Another gold occurrence, referred to as the Alcida East occurrence, is reported in the west region of the property. Historic samples from the Alcida East occurrence are reported up to 4.3 g/t Au. Two additional gold occurrences are reported near the west boundary of the property, possibly being west of the Keymet Property. A Qualified Person has not verified any of these gold occurrences. The Company’s focus to data has been the northwest area of the property, northwest of the historic Keymet Mine

Significant precious metal – base metals deposits are reported within 4 km of the Keymet Property. The Elmtree gold deposits are located within 3 km west-southwest of the Keymet Property. A historic mineral resource estimate for the Elmtree gold deposits was reported in 2011 with 294,000 ounces of gold in the indicated + inferred categories reported (0.5 g/t Au cutoff) (source: Murahwi, et al., effective date March 4, 2011 for Micon International Limited, CNRP Mining Inc. and Gorilla Resources Corp.).

The historic Nigadoo River Mine is located approximately 4 km south of the Keymet Property. Polymetallic massive sulfide veins were mined at the Nigadoo River Mine during the 1960s and 1970s with copper, lead, zinc and silver being produced. The N.B Dept. of Energy and Resource Development Mineral Occurrence Database reports shaft depth and production totals at this historic mine. Production during 1967 – 1971 is reported as 1.126 million tonnes at 2.2% Pb, 2.1% Zn, 0.24% Cu and 92.57 g/t Ag. Production during 1973 – 1977 (after a 2 year closure) is reported to be 0.733 million tonnes (only partial metal grades reported). The shaft is reported to at least 470 meter depth.

Readers are warned that mineralization at the Elmtree gold deposits and historic Nigadoo Brook Mine is not necessarily indicative of mineralization on the Keymet Property.

Access to the Keymet Property is excellent with paved roads transecting the property, including a provincial highway. The property covers an area of approximately 3,400 hectares.

 

Historic Keymet Mine (1950s)

To view the graphic in its original size, please click here

 

Readers are warned that historical records referred to in this News Release have been examined but not verified by a Qualified Person. Further work is required to verify that historical records referred to in this News Release are accurate.

David Martin, P.Geo., a Qualified Person as defined by NI 43-101 and VP Exploration for Great Atlantic, is responsible for the technical information contained in this News Release.

About Great Atlantic Resources Corp.: Great Atlantic Resources Corp. is a Canadian exploration company focused on the discovery and development of mineral assets in the resource-rich and sovereign risk-free realm of Atlantic Canada, one of the number one mining regions of the world. Great Atlantic is currently surging forward building the company utilizing a Project Generation model, with a special focus on the most critical elements on the planet that are prominent in Atlantic Canada, Antimony, Tungsten and Gold.

On Behalf of the board of directors

“Christopher R Anderson”

Mr. Christopher R Anderson  “ Always be positive, strive for solutions, and never give up ”

President CEO Director

604-488-3900 – Dir

Tags: , , , , , , ,
Posted in All Recent Posts, Featured, Small and Micro-Cap Space | Comments Off on $GR.ca Great Atlantic Completed Final Payment on Its 100% owned Keymet Precious – Base Metal Property, Bathurst, New Brunswick

BREAKING: Namaste $N.ca $NXTTF Receives ACMPR Medical #Cannabis Production License $ATT.ca $ABCN.ca $ACG.ca $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 4:04 PM on Friday, March 16th, 2018

Nlogo

  • Wholly owned subsidiary, Cannmart has received its Access to Cannabis for Medical Purposes Regulations Production License
  • Cannmart may now place initial orders with ACMPR licensed producers
  • Confident in its ability to execute and complete the final steps towards receiving its Sales License in a timely manner
  • With receipt of the production license, Namaste now expects to execute on its overall vision of becoming an all-inclusive online cannabis marketplace

VANCOUVER, British Columbia, March 16, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that its wholly owned subsidiary, Cannmart Inc. (“Cannmart”) has received its Access to Cannabis for Medical Purposes Regulations (“ACMPR”) Production License (the “License”). Under the guidelines set forth by Health Canada, Cannmart may now place initial orders with ACMPR licensed producers. Upon receipt, packaging and testing of the initial shipments of medical cannabis, the Company is then required to demonstrate compliance with standard operating procedures (“SOPs”) and other ACMPR regulatory requirements with Health Canada. Once these objectives have been achieved and following an initial inspection, Cannmart will be able to book a Pre-Sales License Inspection after which the Company will be eligible to receive its ACMPR Sales License. Cannmart believes it is well prepared and confident in its ability to execute and complete the final steps towards receiving its Sales License in a timely manner.

If Cannmart receives its Sales License, Cannmart will then operate as one of the first aggregators of medical cannabis, sourced from handpicked ACMPR licensed producers. The Company has identified the need for a competitive landscape where patients have the ability to access a larger variety of medical cannabis strains and oils, without the need to change licensed producers. Through a combination of strategic service and supply agreements, Cannmart will be well-positioned to provide Canadian patients with access to a wide range of medical cannabis products through the most diverse online platform in the Canadian cannabis market. Namaste acquired Cannmart as a late-stage ACMPR applicant, with the intention of creating Canada’s most expansive marketplace for medical cannabis. The receipt of the Production License represents a significant milestone for the Company and will help to propel Namaste to become one of Canada’s leading e-commerce retailer of medical cannabis.

Namaste currently operates one of the largest global e-commerce platforms for cannabis delivery devices and plans to leverage its technology and consumer data with the end goal of acquiring medical patients. In order to facilitate growth at an accelerated rate, the Company plans to utilize its recently launched mobile application under its wholly owned subsidiary, NamasteMD Inc. (“NamasteMD”). This revolutionary medical cannabis app is Canada’s first virtual patient consultation portal to be approved by Apple and Google to be used on both iOS and Android devices. NamasteMD will serve the company as a patient acquisition tool, allowing patients to connect with doctors and nurse practitioners in a safe and secure online environment from the comfort of their homes. NamasteMD was designed to streamline the patient onboarding process in comparison to traditional brick-and-mortar clinics.

With receipt of the production license, Namaste now expects to execute on its overall vision of becoming an all-inclusive online cannabis marketplace and creating a platform that consolidates many of the best product offerings by the top ACMPR Licensed Producers in Canada. Namaste believes it can now deliver on its promise of providing patients with a true “one stop shopping” experience. Namaste will continue creating strategic partnerships through various agreements in attempt to innovate in the Canadian medical cannabis industry.

Further to this news release, Namaste will host a special edition Namaste Live420 on the Company’s YouTube channel via the link below, on Monday, March 19th, 2018 at 8:30 AM EDT to discuss and answer shareholder questions.

https://www.youtube.com/watch?v=TOGWr21c-rE&feature=youtu.be

Management Commentary

Sean Dollinger, President and CEO of Namaste comments; “This important milestone represents an incredible achievement for Namaste and its shareholders. Receipt of the ACMPR Production License not only validates Namaste’s strategy but it serves as a critical component of the Company’s anticipated growth moving forward.  We are very proud to have met our goal of receiving our ACMPR medical cannabis Production License from Health Canada as we look to explore the tremendous opportunities that exist in the Canadian cannabis market. While we are excited with this achievement, management remains highly focused on completing the final protocols set forth by Health Canada and plan on executing the final steps towards receiving our “Sales Only” License.  If the Sales Licence is received, we fully intend on leveraging our data and technology through our global network of operations where we believe we will be well-positioned to implement the same strategy in other legal markets where the Company has established strong market share.”

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis sales (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com

namastevapes.ca

everyonedoesit.ca

namastevaporizers.co.uk

everyonedoesit.co.uk

australianvaporizers.com.au

Forward Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The Canadian Securities Exchange has neither reviewed nor approved the contents of this press release.

Tags: , , ,
Posted in All Recent Posts, Featured, Medical Marijuana Stocks, Namaste Technologies Inc. | Comments Off on BREAKING: Namaste $N.ca $NXTTF Receives ACMPR Medical #Cannabis Production License $ATT.ca $ABCN.ca $ACG.ca $ACB $WEED.ca $HIP.ca

Mobile gaming: there’s a new entertainment player in town, Women $KUU.ca #Kuuhubb $TCEHY $ATVI $CYOU

Posted by AGORACOM-JC at 10:17 AM on Friday, March 16th, 2018

  • Research by Google found that women make up 52% of total usage time, illustrating mobile gaming’s attraction to a broad, diverse audience.

A switch to the smaller screen

It’s no secret that games consoles dating as far back as the Sega Mega Drive and Nintendo SNES have enjoyed pride of place in living rooms around the world, providing a welcome dose of entertainment and a brief escape from reality.

But, thanks to incredible advances in mobile technology – just look at the iPhone X and Google Pixel 2 – gaming on the small screen in your pocket is giving the latest consoles a run for their money. And that means big opportunities for marketers.

Mobile makes its mark

Back in 2012, people spent just over an hour a day using a mobile device online.

In the five years since, this has risen to over three hours, according to WARC. In 2017, mobile advertising spend overtook desktop for the first time, and it now stands to become a staple advertising platform – afforded the level of thought and attention currently demanded by more traditional channels like TV and cinema.

women make up 52% of total usage time

Once, mobile gaming may have been tarred with the archetypal young, male gamer brush – but this profile is long since out of date. Research by Google, for example, found that women make up 52% of total usage time, illustrating mobile gaming’s attraction to a broad, diverse audience.

That makes it a powerful branding tool, and brands are taking note. According to a report by Sensor Tower, mobile spending – driven by games – was up globally across the board in 2017.

Gaming’s huge potential for brands

The opportunity for brands lies in tapping into this huge, entertainment-seeking audience through relevant content in the context of the game being played. We are working with companies like Disney and Universal to realise the potential of mobile gaming.

But marketers need to remember, when it comes to mobile, how precious and personal our devices are to us.

Disruptive banner ads or invasive pop-ups appearing on personal devices can easily irritate consumers – especially when screens are small enough to cause accidental clicks. We need to ensure that we are only serving content that adds to the experience.

Creating branded mini-games and sponsored in-game events, carefully tailored to players’ interests, will see players develop positive affiliations with branded advertising. It’s a simple method, but one we know works.

Mobile’s growth shows no sign of slowing, and brands need to act on the unique role mobile gaming can play in the entertainment mix.

Source: https://www.marketingtechnews.net/news/2018/mar/12/mobile-gaming-theres-new-entertainment-player-town/

Tags: , , , , , ,
Posted in All Recent Posts, Featured, Kuuhubb | Comments Off on Mobile gaming: there’s a new entertainment player in town, Women $KUU.ca #Kuuhubb $TCEHY $ATVI $CYOU

FEATURE: $AAO.ca Why Augusta Industries is an under valued company

Posted by AGORACOM at 1:43 PM on Thursday, March 15th, 2018

 

 

Augusta Industries Subsidiary FOX-TEK Canada Inc is a rare Gem of a tech company where its technology, potential and capabilities are undervalued and therefore discounted. Investors don’t seem to appreciate that FOX TEK is making great strides with its available resources while developing industry disruptive technology capable of meeting current value expectations. The patient investor understands and values a company that is creating new and disruptive technological tools

Sales and revenue evaluation of a company is great when you are invested in GE, FORD, GM, IBM and Apple, but the real value missed here by a few shareholders is what FOX-TEK’s engineers are able to create. FOX TEK first started with the FT Systems as its sole technology and below is living proof of what FOX-TEK has been able to create.

1) Electric Field Mapping (EFM) Corrosion monitor

Used predominately to measure, with great accuracy, the material loss in pipelines and vessels due to corrosion/erosion. The technology has been successfully used as a validation of existing integrity programs. The technology can also be used in research and material testing applications.

2) Fiber Bragg Grating (FBG) System

Technology based on optical strain sensors. These sensors are inherently safe (due to the fact that the sensors are powered by light) and easy to use. Due to the high bandwidth of the sensors, they can also be used to measure vibrations. There many applications in both the oil & gas sector and civil infrastructure where these sensors can bring a benefit.

3) FG-OD

Novel non intrusive leak detection technology used to detect leaks in pipelines and vessels. Due to its high sensitivity, the sensor cable can also detect VOC due to leaks.  By using smart detection levels and adapting to its environment, this technology will generate zero false alarms.

4) Advanced Sensor Design

Advanced intrusive optical sensor that will, over time, change its optical characteristics when in the presence of various elements. Can be used in applications where specific trace elements can lead to a negative impact on normal operating conditions.

5) Currently as per FOX-TEK’s last Press release, working to develop a new technology to measure the ingress of damaging liquids under insulation/coating. This LOI is indicative of the confidence major parties involved have in the burgeoning technology, be it Federal, Provincial Academic or Business.

http://www.fox-tek.com/home.php

 

Tags: , , , , , , , , ,
Posted in AGORACOM Client Feature, AGORACOM News And Events, All Recent Posts, Featured, Small and Micro-Cap Space | Comments Off on FEATURE: $AAO.ca Why Augusta Industries is an under valued company

FEATURE: $GGX.ca Completes 3 Holes at Gold Drop $TUE.ca $MTB.ca $GTT.ca

Posted by AGORACOM at 12:59 PM on Wednesday, March 14th, 2018

 

GGX Gold Corp. (TSXV: GGX), has completed the first three holes of the 2018 Phase III Diamond Drilling program on the Gold Drop Property near Greenwood, BC. The program currently underway is targeting the COD Vein in the Gold Drop Southwest Zone.

The first three holes of the current program have now been successfully completed for a total of 212.45 meters. These holes were designed to further delineate the COD vein at depth.

The holes were stepped back from the 2017 pads to target the vein at depth.

DDCOD18-1 – intersected a 2.81 m Mineralized Zone which includes a 1.2 meter Vein intercept

DDCOD18-2 – intersected a 4.3 m Mineralized Zone which includes 2.92 meters of veining and alternation further at a depth of down the hole was a 7.5 altered shear zone that was erratically mineralized.

DDCOD18-3 – intersected a 6.64 m Mineralized Zone which includes 2.33 Meters of veining and alteration

 

The Gold Drop Project is located 40 km from Grand Forks, British Columbia in geologically prospective ground in the well-mineralized Greenwood District. GGX Gold saw a very successful season in 2017 and has extensive plans to follow up in 2018. The Phase III drilling program of up to 1000 Meters is being designed to follow up on data obtained from the 2017 drill program that consisted of approximately 1500 M. The 2017 program was drilled along the COD Vein which was previously exposed in trenching accompanied with channel sampling. The current drill sites for phase III are at various locations along the previously exposed COD vein and Additionally, new drill sites have also been spotted for locations to the north and south of the exposed COD vein. These areas have yet to be trenched, however the company has recently identified gold anomalies in soils and is permitted for 850M of trenching. (Soils -News Release–Jan-10-18)

Tags: , ,
Posted in AGORACOM Client Feature, All Recent Posts, Featured, Small and Micro-Cap Space | Comments Off on FEATURE: $GGX.ca Completes 3 Holes at Gold Drop $TUE.ca $MTB.ca $GTT.ca

PyroGenesis $PYR.ca is Nominated for “Materials Company of the Year” at the #3D Printing Industry Awards 2018

Posted by AGORACOM-JC at 8:44 AM on Wednesday, March 14th, 2018

Pyr header 1

  • Announced today that PyroGenesis has been nominated to the shortlist for “Materials Company of the Year” at the 3D Printing Industry Awards 2018
  • Nominations, and winners are decided by a public vote

MONTREAL, March 14, 2018 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V:PYR), (the “Company”, the “Corporation” or “PyroGenesis”) a Company that designs, develops and manufactures plasma waste-to-energy systems and plasma torch systems, is pleased to announce today that PyroGenesis has been nominated to the shortlist for “Materials Company of the Year” at the 3D Printing Industry Awards 2018.

Nominations, and winners are decided by a public vote.

https://3dprintingindustry.com/news/2018-3d-printing-industry-awards-vote-now-130133/.

“We are truly honored to have been recognized by the industry with this shortlist nomination,” said P. Peter Pascali, CEO and President of PyroGenesis. “Notwithstanding the outcome, the fact that we were barely known this time last year, and now we are being considered, with such prestigious names, confirms that our strategy to produce powders, once again, for the additive manufacturing industry, was the correct one. As the inventors of plasma atomization, our goal is to continue to innovate and enable the industry to achieve new heights. We thank you all for the confidence you have placed in us.”

PyroGenesis Additive is also pleased to announce that Mr. Massimo Dattilo, VP, PyroGenesis Additive, and Mr. Alex Pascali, Business Development Manager, PyroGenesis Additive will be attending the 3D Printing Industry Awards in London, England on May 17th, 2018 at which time the winners will be announced.

About PyroGenesis Additive
PyroGenesis Additive, a division of PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V:PYR), (the “Company”, or “PyroGenesis”), the inventor of Plasma Atomization, specializes in providing plasma atomized spherical metallic powders with some of the most spherical, pure, dense, and highly flowable properties, which are highly sought after in the Additive Manufacturing (“AM”) and Metal Injection Molding (“MIM”) Industry. With PyroGenesis’ extensive plasma expertise, PyroGenesis Additive is not only able to convert traditional metals and alloys into high purity spherical powders, but also create specialty powders on an exclusive basis. The versatility of the process allows PyroGenesis Additive to quickly adapt to a customer’s needs in terms of controlling the Particle Size Distribution (PSD) of the bulk powder, it can produce any size cut with little to no waste which is game changing for the industry as it significantly reduces costs to the end-user. The metal powders produced by PyroGenesis Additive are ideal for the additive manufacturing, aerospace, biomedical, thermal spray, and metal injection molding industries.

About PyroGenesis Canada Inc.
PyroGenesis Canada Inc. is the world leader in the design, development, manufacture and commercialization of advanced plasma processes. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2008 certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact: Rodayna Kafal, VP, Investor Relations and Strategic Business Development, Phone: (514) 937-0002, E-mail: [email protected]

RELATED LINKS: http://www.pyrogenesis.com/

Tags: , , ,
Posted in All Recent Posts, Featured, PyroGenesis Canada Inc. | Comments Off on PyroGenesis $PYR.ca is Nominated for “Materials Company of the Year” at the #3D Printing Industry Awards 2018

Tetra Bio-Pharma $TBP.ca Announces #FDA Orphan Drug Designation for PPP001 in Treatment of Complex Regional Pain Syndrome $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 8:30 AM on Wednesday, March 14th, 2018

Logo tetrabiopharma rgb web

  • Announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to the active ingredients of its PPP001 drug for the treatment of complex regional pain syndrome 
  • FDA Orphan Drug Designation program provides orphan status to drugs intended to treat rare diseases or disorders that affect less than 200,000 people in the USA
  • Gives Tetra a seven-year marketing exclusivity, after drug approval by the FDA

OTTAWA, ONTARIO–(March 14, 2018) – Tetra Bio-Pharma Inc. (“Tetra” or the “Corporation“) (TSX VENTURE:TBP)(OTCQB:TBPMF), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the active ingredients of its PPP001 drug (delta-9-tetrahydrocannabinol 9.5% and cannabidiol 2.5%) for the treatment of complex regional pain syndrome (CRPS). The Orphan Drug Designation was granted for the active moiety of the drug PPP001 and not the formulation.

The FDA Orphan Drug Designation program provides orphan status to drugs intended to treat rare diseases or disorders that affect less than 200,000 people in the USA. This designation gives Tetra a seven-year marketing exclusivity, after drug approval by the FDA, and provides Tetra potential incentives such as access to federal grants and tax credits as well as a waiver of Prescription Drug User Fee Act filing fees.

Tetra successfully completed a placebo-controlled Phase 1a and 1b study of PPP001 in healthy volunteers and demonstrated that PPP001 can be safely consumed. “We are pleased to receive FDA Orphan Drug Designation for PPP001 and we look forward to discussing the clinical program with the US FDA that will be used to demonstrate the safety and efficacy in patients suffering from CRPS,” said Guy Chamberland, M.Sc., Ph.D., Chief Scientific Officer of Tetra.

According to the USA National Institute of Health, “complex regional pain syndrome (CRPS) is a chronic pain condition that most often affects one limb (arm, leg, hand, or foot) usually after an injury. CRPS is believed to be caused by damage to, or malfunction of, the peripheral and central nervous systems. CRPS is characterized by prolonged or excessive pain and changes in skin color, temperature, and/or swelling in the affected area.”

Appointment of a New Director – Tetra also announced the appointment of a new Director, Mr. Benoit Chotard, effective immediately. Mr. Chotard was previously a member of the Board of Directors from September 2016 to July 2017, he left for personal reasons, no longer applicable, and is pleased to come back. “We are glad to welcome back Mr. Chotard to the board and we look forward to working closely with him in building Tetra as a leading biopharmaceutical organization,” said Andre Rancourt, Chairman of Tetra Bio-Pharma. “Mr. Chotard’s tremendous experience as an advisor of publicly listed companies will be a huge addition to our team. His local and international network will be a key factor in the Company’s growth.”

Benoit Chotard is a corporate finance & development executive who has over 20 years of international corporate finance, management and public market expertise. Previously, Mr. Chotard was employed as managing partner at Capital Force United, as President & CEO, and Director of Orletto Capital Inc., Vice-president Corporate Development for Pakit Inc., Senior Vice-president Finance Corporate Development and acting as Chief Financial Officer for CANTRONIC Systems (Canada) Inc., Vice-President Chief Financial Officer of Victhom Human Bionics, and spent eight years as Head of the Technology Investment Group of National Bank Financial Inc.

Mr. Chotard has been a Member of “Ordre des ingénieurs du Québec” since 1989 and obtained a bachelor’s degree in Chemical Engineering (1989) and a MBA (1993) from the Université de Sherbrooke.

About PPP001:

PPP001 aims to be the first smokable marihuana for advanced cancer pain under prescription. It is a dried cannabis pellet designed to be smoked in an inhalation device specifically developed for this product. PPP001 is a unique blend of 3 strains of standardized dried cannabis, creating a drug substance with 9.5% THC and 2.5% CBD.

About Tetra Bio-Pharma:

Tetra Bio-Pharma (TSX VENTURE:TBP)(OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra is focusing on three core business pillars: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based products.

More information at: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Corporation believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Corporation’s ability to control or predict, that may cause the actual results of the Corporation to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the failure to obtain sufficient financing to execute the Corporation’s business plan; the success of the Rx Princeps™ product offering and inhalation device; guidance on expected sales volumes associated with the Rx Princeps™ product offering and inhalation device; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Corporation’s public disclosure record on file with the relevant securities regulatory authorities. Although the Corporation has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Corporation does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Dr. Anne-Sophie Courtois, DVM
Vice President, Marketing & Communications
(438) 899-7575

For media information, please contact:
Daniel Granger
[email protected]
ACJ Communication
O: 1 514 840 7990 / M: 1 514 232 1556

For investors information, please contact:
[email protected]
(438) 504-5784

Tags: , , , , ,
Posted in All Recent Posts, Featured, Medical Marijuana Stocks, Tetra Bio-Pharma Inc. | Comments Off on Tetra Bio-Pharma $TBP.ca Announces #FDA Orphan Drug Designation for PPP001 in Treatment of Complex Regional Pain Syndrome $AERO $CBDS $CGRW $APH.ca $GBLX

Namaste $N.ca $NXTTF Announces LOI With Inolife R&D to Conduct a Research Study to Evaluate Needle-Free Injection Technologies for Medical Cannabis $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 8:53 AM on Monday, March 12th, 2018

Nlogo

  • Signed a non-binding LOI with Inolife R&D Inc.
  • To initiate a research study to evaluate applications for Inolife’s proprietary needle-free injectors in the medical cannabis industry

VANCOUVER, British Columbia, March 12, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that it has signed a non-binding LOI with Inolife R&D Inc. (“Inolife”), whereby Namaste and Inolife will negotiate the terms of a definitive agreement (the “Agreement”) to initiate a research study to evaluate applications for Inolife’s proprietary needle-free injectors in the medical cannabis industry. Under the terms of the LOI and proposed Agreement, Namaste will hold exclusive rights to research and distribute Inolife’s needle-free injection technologies for applications in the cannabis industry. Namaste will also participate in Inolife’s anticipated private placement by acquiring up to 10% of the shares issued under the offering. Inolife will also provide Namaste with the right to acquire up to an additional 10% of the shares issued under the offering at the same price. Additionally, Namaste will purchase up to 10% of the shares issued in connection with Inolife’s go-public transaction for approximately $250,000. Namaste believes that Inolife’s needle-free technologies could revolutionize dosage and administration of cannabis for medical purposes.

The LOI and proposed Agreement represent a strategic initiative for Namaste’s continued effort to offer innovative products to the medical cannabis market. Namaste believes that Inolife’s technology provides the most accurate and efficient method for dosing with medical cannabis. Namaste expects to work within Health Canada’s current and future cannabis regulations, when proceeding towards commercialization of pre-filled needle-free syringes. Namaste expects to commercialize the pre-filled needle-free syringes through its wholly owned subsidiary and late-stage applicant under Access to Cannabis for Medical Purposes Regulations (“ACMPR”), Cannmart Inc. The Company also expects to engage with Canadian ACMPR medical cannabis producers to co-brand medical cannabis oil, to be sold and used for applications with Inolife’s technology.

Key Terms of the LOI

  • Namaste will initiate a research study to determine the viability to use Inolife’s needle-free injectors for medical cannabis.
  • Namaste will bear all costs for research and development.
  • Namaste will participate for up to 10% of Inolife’s anticipated private placement and go-public transaction.
  • Namaste will have exclusive rights to distribute Inolife’s products for the purposes of use with medical cannabis.
  • Both parties agree to a 30-day period from the execution date of the LOI to negotiate terms of a definitive agreement and establish a protocol to proceed with a research study.

Management Commentary

Michael Wright, President and CEO of Inolife comments, “We’re very excited about the proposed partnership with Namaste. We feel that Namaste is best positioned to deliver on our strategic plan to become an innovator of delivery systems for the medical cannabis industry. We’re pleased to be the first company, in partnership with Namaste, to explore needle-free device technology in the context of medical cannabis delivery.”

Sean Dollinger, President and CEO of Namaste comments, “We are very pleased to announce this LOI and our expectation of providing research and development of this innovative technology for applications with medical cannabis. We believe that Inolife’s technology could provide the most efficient and accurate method for dosing with medical cannabis. We see a massive opportunity to revolutionize the industry by bringing this exciting technology to the medical cannabis market. We’re delighted to see that industry-leading companies like Inolife are recognizing Namaste for its value in its database, platform and brand.”

About Inolife R&D Inc.
Inolife R&D Inc. is an emerging specialty medical device company focused on developing and commercializing self-administered medical products using novel drug delivery technologies. The company was founded to take advantage of novel techniques of liquid jet and ballistics-based epidermal drug injection that we believe will improve a patient’s quality of life by making medicines easier to self-administer, work better, and remove the anxiety and inconvenience associated with hypodermic needle injections.

About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors,

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com
namastevapes.ca
everyonedoesit.ca
namastevaporizers.co.uk
everyonedoesit.co.uk
australianvaporizers.com.au

For more information about Inolife R&D Inc. and its products please visit inolifesciences.com
Michael Wright
President, CEO
Direct: 1-866-834-3777
Email: [email protected]

Forward Looking Information
This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The Canadian Securities Exchange has neither reviewed nor approved the contents of this press release.

Tags: , , , , , ,
Posted in All Recent Posts, Featured, Medical Marijuana Stocks, Namaste Technologies Inc. | Comments Off on Namaste $N.ca $NXTTF Announces LOI With Inolife R&D to Conduct a Research Study to Evaluate Needle-Free Injection Technologies for Medical Cannabis $ACB.ca $HIP.ca $WEED.ca $CMED.ca

« Older Entries
Newer Entries »